FGB rs1800788: What Your Genotype Means
The rs1800788 variant is a genetic change located within the FGB gene, which provides instructions for creating a key component of the blood-clotting protein fibrinogen. Research has explored its statistical association with plasma fibrinogen levels and potential links to cardiovascular health, though the clinical significance remains a subject of ongoing study.
What each genotype means
Typical fibrinogen regulation
This genotype represents the most common form of the FGB gene variant. Research suggests this version is associated with baseline fibrinogen biosynthesis levels in the general population, though individual fibrinogen levels are influenced by a complex interplay of genetic and environmental factors.
This is the most frequent genotype observed in most global populations.
Intermediate fibrinogen regulation
Carrying one copy of the T allele may modulate how your body regulates fibrinogen production in response to inflammatory signals like interleukin-6. While some studies have explored links between this variant and cardiovascular disease susceptibility, the evidence remains limited and inconsistent across different ancestral groups.
Carried by a significant portion of individuals of European ancestry, with a minor allele frequency typically ranging between 0.15 and 0.25.
Potential altered fibrinogen regulation
This genotype is associated with the minor allele of the FGB variant, which has been studied for its potential role in fibrinogen biosynthesis and cardiovascular risk. Because this association is influenced by gene-gene interactions and environmental factors, it is not a diagnostic indicator; please discuss any concerns regarding cardiovascular health or blood markers with your clinician.
This genotype is less common than the C/C or C/T genotypes, occurring in a smaller percentage of the population.
Understanding the rs1800788 Variant
The rs1800788 variant is a single nucleotide polymorphism (SNP) situated within the FGB gene on chromosome 4. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant is often studied in the context of the fibrinogen gene cluster, which includes the FGA, FGB, and FGG genes. These genes work together to produce fibrinogen, a soluble plasma glycoprotein essential for the body's blood-clotting process. Because rs1800788 is located in a region that influences gene regulation, researchers investigate whether it alters how much fibrinogen the liver produces. While it is a well-documented marker in genetic databases, it is important to recognize that being a carrier of a specific allele does not determine a health outcome, but rather contributes to the complex, polygenic landscape of human traits.
The Role of the FGB Gene
The FGB gene encodes the beta chain of the fibrinogen protein. Fibrinogen is a critical component of the coagulation cascade; when an injury occurs, the body converts soluble fibrinogen into insoluble fibrin strands, which form the structural matrix of a blood clot. Beyond its role in hemostasis, fibrinogen is also recognized as an acute-phase reactant, meaning its levels in the blood can rise in response to systemic inflammation. Because the FGB gene is central to both clotting and inflammatory responses, variations within or near this gene are frequently analyzed in studies looking at cardiovascular risk factors. Understanding the function of FGB helps researchers hypothesize how regulatory variants might influence the baseline levels of fibrinogen in the blood, which in turn may affect how the body responds to vascular stress or injury.
Research and Evidence Strength
Scientific evidence linking rs1800788 to clinical outcomes is considered limited and sometimes inconsistent. Some genome-wide association studies (GWAS) have identified statistical correlations between this variant and variations in plasma fibrinogen levels. Other studies have investigated its potential association with cardiovascular conditions, such as myocardial infarction, with some reporting higher odds ratios in specific populations. However, these findings are not universal; other large-scale studies have found no significant predictive power for the variant regarding ischemic heart disease. The discrepancy in results often stems from differences in study design, population ancestry, and the influence of environmental factors like smoking or diet, which also impact fibrinogen levels. Consequently, while the variant is a useful tool for researchers mapping the genetic architecture of blood proteins, it is not currently used as a standalone clinical diagnostic tool for predicting heart disease.
Population Frequency
The rs1800788 variant is relatively common, with the minor allele frequency typically reported between 0.15 and 0.25 in European populations. Frequency can vary significantly across different global ancestries, reflecting the natural diversity of human genetic variation. Because it is a common variant, a large portion of the population carries at least one copy of the minor allele, which underscores why it is frequently captured in large-scale genetic association studies.
Interpreting Your Genetic Information
If you have access to your genetic data regarding rs1800788, it is important to view this information in the context of your overall health profile. Genetic variants are only one piece of a much larger puzzle that includes lifestyle, environment, and other genetic factors. This variant is not a diagnostic test for cardiovascular disease, and the presence of a specific genotype does not mean you will develop a particular condition. If you are concerned about your cardiovascular health or blood-clotting factors, the most effective approach is to consult with a healthcare professional. They can evaluate your clinical history, perform standard blood tests, and provide personalized guidance. Never use genetic data to make decisions about medications or treatments without first discussing them with your doctor or a qualified pharmacist, as they can provide the necessary context for your specific health needs.
How common is this variant?
The minor allele frequency for rs1800788 is approximately 0.15-0.25 in European populations, though frequencies vary across global ancestries.
Frequently asked questions
Is rs1800788 a cause of heart disease?
No, rs1800788 is not considered a direct cause of heart disease. While some studies have found statistical associations between this variant and cardiovascular traits, it is not a diagnostic marker and does not determine whether an individual will develop heart disease.
Does this variant affect my fibrinogen levels?
Some research suggests that this variant may be associated with variations in plasma fibrinogen levels. However, these levels are also heavily influenced by non-genetic factors such as inflammation, smoking, and overall health status.
Should I change my medication based on this genotype?
No. You should never change your medication or treatment plan based on genetic test results without consulting your doctor or pharmacist. Genetic variants are only one factor in how your body responds to medication.
Where can I find more information on FGB?
You can find reliable information about the FGB gene and its function through resources like MedlinePlus Genetics or the GeneCards database. These sites provide comprehensive summaries of gene function and related research.
Sources & further reading
Educational information only, last refreshed 10/16/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1800788?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29